EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

TDP‐43 Aggregation: The Healthy‐Toxic Balance of the Prion‐Like Domain

Luca Zangrando, Emanuele Buratti iD, Francesca Paron

Advanced Science · 2026

DOI: 10.1002/advs.76119 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Science, 2026. Verfasst von Luca Zangrando und 2 weiteren Autor:innen. Beteiligte Einrichtung: Life Science Department, University of Trieste, Trieste, Italy. Hauptthemen laut MEDLINE: Protein Aggregation, Pathological, DNA-Binding Proteins, RNA-Binding Proteins, Prions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 267 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AriSLA 2022-NOSRESCUEALS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TAR DNA‐binding protein 43 (TDP‐43) is a ubiquitously expressed RNA‐binding protein that plays essential roles in RNA metabolism, including transcription, splicing, transport, and stability. Pathological TDP‐43 aggregates have become a defining hallmark of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and a large subset of frontotemporal lobar degeneration (FTLD). In the last decade, increasing evidence has challenged the initial thought of TDP‐43 condensates as a purely pathological event, highlighting instead the physiological relevance of reversible self‐association, polymerization and liquid‐liquid phase separation (LLPS) in regulating TDP‐43 functions. In this review, we provide an integrated overview of the structural determinants governing TDP‐43 two‐faced polymerization, with a particular focus on the prion‐like domain and its parallelism with prion proteins. Indeed, while physiological assemblies support normal RNA processing, the dysregulation of LLPS by either disease‐associated mutations, altered RNA‐binding, aberrant post‐translational modifications, or proteolytic cleavage can promote the transition toward irreversible, pathogenic aggregates. Finally, we summarize strategies aimed at eliminating TDP‐43 aggregates or modulating its phase‐separation behavior. Altogether, this review frames TDP‐43 polymerization in both healthy and pathological conditions, offering a prion‐like centered view of TDP‐43 proteinopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Aggregation, PathologicalDNA-Binding ProteinsRNA-Binding ProteinsPrionsRNA Processing, Post-TranscriptionalNeurodegenerative DiseasesProtein AggregatesProtein DomainsPhase SeparationMutationProtein Processing, Post-TranslationalProteolysisPolymerizationHumansTDP-43 Proteinopathies

Stichwörter der Autor:innen

LLPSTDP‐43neurodegenerationprion‐like domainprotein aggregationtherapeutic strategies

Substanzen

TARDBP protein, humanDNA-Binding ProteinsRNA-Binding ProteinsPrionsProtein Aggregates

Autor:innen und Institutionen

  • Life Science Department, University of Trieste, Trieste, Italy.
  • Molecular Pathology, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.

ORCID-Profile: Emanuele Buratti

Förderung

  • AriSLA 2022-NOSRESCUEALS

Zitieren

APA

Zangrando, L., Buratti, E., & Paron, F. (2026). TDP‐43 Aggregation: The Healthy‐Toxic Balance of the Prion‐Like Domain. Advanced Science. https://doi.org/10.1002/advs.76119

Vancouver

Zangrando L, Buratti E, Paron F. TDP‐43 Aggregation: The Healthy‐Toxic Balance of the Prion‐Like Domain. Advanced Science. 2026. doi:10.1002/advs.76119

BibTeX
@article{Zangrando2026,
  author = {Zangrando, Luca and Buratti, Emanuele and Paron, Francesca},
  title = {TDP‐43 Aggregation: The Healthy‐Toxic Balance of the Prion‐Like Domain},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76119}
}
Kostenlos starten →